EP Patent

EP0917457A1 — Biphasic multicomponent pharmaceutical dosage forms containing substances able to modify the partitioning of drugs

Assigned to Adare Pharmaceuticals SRL · Expires 1999-05-26 · 27y expired

What this patent protects

Biphasic multicomponent pharmaceutical compositions, consisting of an oil phase and a water phase comprising compounds able to modifiy the partition of the active principles between said phases and their percutaneous, transdermal and transmucosal adsorption.

USPTO Abstract

Biphasic multicomponent pharmaceutical compositions, consisting of an oil phase and a water phase comprising compounds able to modifiy the partition of the active principles between said phases and their percutaneous, transdermal and transmucosal adsorption.

Drugs covered by this patent

Patent Metadata

Patent number
EP0917457A1
Jurisdiction
EP
Classification
—
Expires
1999-05-26
Drug substance claim
No
Drug product claim
No
Assignee
Adare Pharmaceuticals SRL
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.